Cargando…

Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer

BACKGROUND: Using a genome-wide approach, we have previously observed an increase in the frequency of rare copy number variants (CNVs) in familial and early-onset breast cancer cases when compared to controls. Moreover, the biological networks of the CNV disrupted genes differed between the two grou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tervasmäki, Anna, Winqvist, Robert, Jukkola-Vuorinen, Arja, Pylkäs, Katri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265448/ https://www.ncbi.nlm.nih.gov/pubmed/25466287 http://dx.doi.org/10.1186/1471-2407-14-902

Ejemplares similares

Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility
por: Mantere, Tuomo, et al.
Publicado: (2016)

Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression Network
por: Pylkäs, Katri, et al.
Publicado: (2012)

ATM c.7570G>C is a high‐risk allele for breast cancer
por: Kankuri‐Tammilehto, Minna, et al.
Publicado: (2022)

Evaluating the role of NTHL1 p.Q90* allele in inherited breast cancer predisposition
por: Kumpula, Timo, et al.
Publicado: (2020)

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
por: Kiiski, Johanna I., et al.
Publicado: (2017)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families
por: Haanpää, Maria, et al.
Publicado: (2013)

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
por: Jääskeläinen, Anniina, et al.
Publicado: (2018)

Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families
por: Pylkäs, Katri, et al.
Publicado: (2008)

Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility
por: Koivuluoma, Susanna, et al.
Publicado: (2022)

CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases
por: Petruk, Nataliia, et al.
Publicado: (2023)

Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families
por: Vuorela, Mikko, et al.
Publicado: (2011)

Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility
por: Mantere, Tuomo, et al.
Publicado: (2017)

CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Petruk, Nataliia, et al.
Publicado: (2021)

Exome sequencing identified rare recurrent copy number variants and hereditary breast cancer susceptibility
por: Kumpula, Timo A., et al.
Publicado: (2023)

Evaluating the role of CHEK2 p.(Asp438Tyr) allele in inherited breast cancer predisposition
por: Kumpula, Timo A., et al.
Publicado: (2023)

Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
por: VÄISÄNEN, MARJA-RIITTA, et al.
Publicado: (2013)

FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome
por: Kiiski, Johanna I., et al.
Publicado: (2016)

Mutation analysis of the AATF gene in breast cancer families
por: Haanpää, Maria, et al.
Publicado: (2009)

Evaluating the role of MLH3 p.Ser1188Ter variant in inherited breast cancer predisposition
por: Koivuluoma, Susanna, et al.
Publicado: (2019)

The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
por: Peurala, Emmi, et al.
Publicado: (2013)

Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls
por: Behravan, Hamid, et al.
Publicado: (2018)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
por: Hallamies, Sanna, et al.
Publicado: (2017)

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo
por: Sandholm, Jouko, et al.
Publicado: (2016)

Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study
por: Roininen, Nelli, et al.
Publicado: (2017)

High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
por: Jääskeläinen, Anniina, et al.
Publicado: (2020)

Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly
por: Tervasmäki, Anna, et al.
Publicado: (2019)

Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015)

Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort
por: Martini, Rachel, et al.
Publicado: (2021)

Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype
por: Karihtala, P, et al.
Publicado: (2012)

The UGT1A6_19_GG genotype is a breast cancer risk factor
por: Justenhoven, Christina, et al.
Publicado: (2013)

CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells
por: Hollis, Paul R., et al.
Publicado: (2022)

Two Deletion Alleles in the C. elegans mir-49 gene.
por: Delich, Cassandra, et al.
Publicado: (2020)

8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer
por: Sova, H, et al.
Publicado: (2010)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
por: Hancock, Bradley A., et al.
Publicado: (2019)

Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism
por: Tang, Peng-fei, et al.
Publicado: (2020)

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
por: Johnson, Nichola, et al.
Publicado: (2021)

Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients
por: Pogoda, Katarzyna, et al.
Publicado: (2013)

Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer
por: TUOMELA, JOHANNA, et al.
Publicado: (2013)

Three-dimensional radiomics of triple-negative breast cancer: Prediction of systemic recurrence
por: Koh, Jieun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a4chkk38ol08vp26t1fj3ucree